Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Mar;40(3):445–453. doi: 10.1172/JCI104272

EFFECT OF ESTROGENS ON COPPER METABOLISM IN WILSON'S DISEASE*

James L German III 1, Alexander G Bearn 1
PMCID: PMC290741  PMID: 13704653

Full text

PDF
446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEARN A. G. A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration). Ann Hum Genet. 1960 Apr;24:33–43. doi: 10.1111/j.1469-1809.1959.tb01713.x. [DOI] [PubMed] [Google Scholar]
  2. BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
  3. BEARN A. G., KUNKEL H. G. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria. J Clin Invest. 1954 Mar;33(3):400–409. doi: 10.1172/JCI102912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BEARN A. G., KUNKEL H. G. Metabolic studies in Wilson's disease using Cu64. J Lab Clin Med. 1955 Apr;45(4):623–631. [PubMed] [Google Scholar]
  5. BEARN A. G. Wilson's disease; an inborn error of metabolism with multiple manifestations. Am J Med. 1957 May;22(5):747–757. doi: 10.1016/0002-9343(57)90125-0. [DOI] [PubMed] [Google Scholar]
  6. BROMAN L. Separation and characterization of two coeruloplasmins from human serum. Nature. 1958 Dec 13;182(4650):1655–1657. doi: 10.1038/1821655a0. [DOI] [PubMed] [Google Scholar]
  7. BUSH J. A., MAHONEY J. P., MARKOWITZ H., GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration. J Clin Invest. 1955 Dec;34(12):1766–1778. doi: 10.1172/JCI103232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CARTWRIGHT G. E., HODGES R. E., GUBLER C. J., MAHONEY J. P., DAUM K., WINTROBE M. M., BEAN W. B. Studies on copper metabolism. XIII. Hepatolenticular degeneration. J Clin Invest. 1954 Nov;33(11):1487–1501. doi: 10.1172/JCI103027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CARTWRIGHT G. E., MARKOWITZ H., SHIELDS G. S., WINTROBE M. M. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease. Am J Med. 1960 Apr;28:555–563. doi: 10.1016/0002-9343(60)90150-9. [DOI] [PubMed] [Google Scholar]
  10. CORYELL M. N., BEACH E. F., ROBINSON A. R., MACY I. G., MACK H. C. Metabolism of women during the reproductive cycle. XVII. Changes in electrophoretic patterns of plasma proteins throughout the cycle and following delivery. J Clin Invest. 1950 Dec;29(12):1559–1567. doi: 10.1172/JCI102397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DE VRIES S. I. Ijzer -en kopermetabolisme bij zwangeren en pasgeborenen. Ned Tijdschr Verloskd Gynaecol. 1953;53(2-3):137–163. [PubMed] [Google Scholar]
  12. ENGBRING N. H., ENGSTROM W. W. Effects of estrogen and testosterone on circulating thyroid hormone. J Clin Endocrinol Metab. 1959 Jul;19(7):783–796. doi: 10.1210/jcem-19-7-783. [DOI] [PubMed] [Google Scholar]
  13. Eden A., Green H. H. Micro-determination of copper in biological material. Biochem J. 1940 Sep;34(8-9):1202–1208. doi: 10.1042/bj0341202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GUBLER C. J., LAHEY M. E., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. IX. The transportation of copper in blood. J Clin Invest. 1953 May;32(5):405–414. doi: 10.1172/JCI102752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HOCH-LIGETI C., IRVINE K. Effects of hormone administration on serum protein patterns. Proc Soc Exp Biol Med. 1954 Nov;87(2):324–328. doi: 10.3181/00379727-87-21369. [DOI] [PubMed] [Google Scholar]
  16. HOLMBERG C. G., LAURELL C. B. Oxidase reactions in human plasma caused by coeruloplasmin. Scand J Clin Lab Invest. 1951;3(2):103–107. doi: 10.3109/00365515109060581. [DOI] [PubMed] [Google Scholar]
  17. LAHEY M. E., GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. VII. Blood copper in pregnancy and various pathologic states. J Clin Invest. 1953 Apr;32(4):329–339. doi: 10.1172/JCI102743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Longsworth L. G., Curtis R. M., Pembroke R. H. THE ELECTROPHORETIC ANALYSIS OF MATERNAL AND FETAL PLASMAS AND SERA. J Clin Invest. 1945 Jan;24(1):46–53. doi: 10.1172/JCI101577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. MARKOWITZ H., GUBLER C. J., MAHONEY J. P., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. J Clin Invest. 1955 Oct;34(10):1498–1508. doi: 10.1172/JCI103201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. MUELLER G. C. A discussion of the mechanism of action of steroid hormones. Cancer Res. 1957 Jun;17(5):490–506. [PubMed] [Google Scholar]
  21. RAYMUNT J., RUSS E. M. Influence of estrogens on total serum copper and caeruloplasmin. Proc Soc Exp Biol Med. 1956 Jul;92(3):465–466. doi: 10.3181/00379727-92-22512. [DOI] [PubMed] [Google Scholar]
  22. ROBBINS J., NELSON J. H. Thyroxinebinding by serum protein in pregnancy and in the newborn. J Clin Invest. 1958 Feb;37(2):153–159. doi: 10.1172/JCI103593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. ROSENOER V. M., FRANGLEN G. Caeruloplasmin in Wilson's disease. Lancet. 1959 Dec 26;2(7113):1163–1164. doi: 10.1016/s0140-6736(59)91739-8. [DOI] [PubMed] [Google Scholar]
  24. RUSS E. M., RAYMUNT J., PILLAR S. Effect of estrogen therapy on ceruloplasmin concentration in a man with Wilson's disease. J Clin Endocrinol Metab. 1957 Jul;17(7):908–909. doi: 10.1210/jcem-17-7-908. [DOI] [PubMed] [Google Scholar]
  25. SANDBERG A. A., SLAUNWHITE W. R., Jr Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens. J Clin Invest. 1959 Aug;38(8):1290–1297. doi: 10.1172/JCI103904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SASS-KORTSAK A., CHERNIAK M., GEIGER D. W., SLATER R. J. Observations on ceruloplasmin in Wilson's disease. J Clin Invest. 1959 Oct;38:1672–1682. doi: 10.1172/JCI103945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
  28. SCHEINBERG I. H., STERNLIEB I. The liver in Wilson's disease. Gastroenterology. 1959 Nov;37:550–564. [PubMed] [Google Scholar]
  29. Thompson R. H., Watson D. Serum Copper Levels in Pregnancy and Pre-Eclampsia. J Clin Pathol. 1949 Aug;2(3):193–196. [PMC free article] [PubMed] [Google Scholar]
  30. VILLEE C. A. Some current speculations on the action of estrogens. Perspect Biol Med. 1959;2(3):290–308. doi: 10.1353/pbm.1959.0009. [DOI] [PubMed] [Google Scholar]
  31. VON STUDNITZ W., BEREZIN D. Studies on serum copper during pregnancy, during the menstrual cycle, and after the administration of oestrogens. Acta Endocrinol (Copenh) 1958 Feb;27(2):245–252. doi: 10.1530/acta.0.0270245. [DOI] [PubMed] [Google Scholar]
  32. VON STUDNITZ W. Studies on serum proteins in pregnancy. Scand J Clin Lab Invest. 1955;7(4):324–328. doi: 10.3109/00365515509134672. [DOI] [PubMed] [Google Scholar]
  33. WALSHE J. M. Changing concepts of the pathogenesis of Wilson's disease. Ann Intern Med. 1959 Nov;51:1110–1115. doi: 10.7326/0003-4819-51-5-1110. [DOI] [PubMed] [Google Scholar]
  34. WALSHE J. M. Current views on the pathogenesis and treatment of Wilson's disease. AMA Arch Intern Med. 1959 Jan;103(1):155–161. doi: 10.1001/archinte.1959.00270010161021. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES